Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Consun Pharmaceutical Group

Consun Pharmaceutical Group
1997 FOUNDED
PUBLIC STATUS
1K-5K EMPLOYEES
01681 STOCK SYMBOL
2 INVESTMENTS
$0.57 SHARE PRICE (As of Tuesday Closing)
Description

Consun Pharmaceutical Group is a biotechnology company with sales operations throughout China. Its principal activities are making and selling pharmaceutical products. The company has two reportable segments: the Consun pharmaceutical segment, which is the key revenue driver, makes and sells modern Chinese medicines and medical contrast medium, and the Yulin pharmaceutical segment, which manufactures and sells traditional Chinese medicines. Consun derives revenue from kidney medicines, contrast medium, orthopedics medicines, dermatologic medicines, hepatobiliary medicines, medicines for women and children, and others.

Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Stock Exchange
HKG
Primary Office
  • 71, Dongpeng Avenue Eastern section
  • Guangzhou Economic and Technological Development D
  • Guangzhou, Guangdong 510760
  • China
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Consun Pharmaceutical Group’s full profile, request a free trial.

Consun Pharmaceutical Group Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$0.52 - $0.81 $492M $0.57 $0.09 1.21M 865M

Consun Pharmaceutical Group Financials Summary

In Thousands,
USD
TTM
30-Jun-2019
FY 2018
31-Dec-2018
FY 2017
31-Dec-2017
FY 2016
31-Dec-2016
Enterprise Value 514,233 456,367 821,983 416,550
Revenue 280,814 278,745 245,671 183,684
EBITDA 94,090 105,729 91,707 66,375
Net Income 72,668 70,345 58,633 46,169
Total Assets 609,345 566,512 547,126 397,341
Total Debt 103,696 57,063 87,017 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Consun Pharmaceutical Group Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Consun Pharmaceutical Group‘s full profile, request access.

Request full access to PitchBook

Consun Pharmaceutical Group Investments & Acquisitions (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000 00000 0000 16-Aug-2016 000000000 00000000 000.00 Drug Discovery
Guangxi Yulin Pharmaceutical 09-Nov-2015 Merger/Acquisition 00000 Drug Discovery
To view this company’s complete investment and acquisition history, request access »

Consun Pharmaceutical Group Subsidiaries (1)

Company Name Industry Location Founded
0000000 00000 0000 Drug Discovery Yulin, China 0000
To view this company’s complete subsidiary history, request access »

Consun Pharmaceutical Group Executive Team (2)

Name Title Board
Seat
Contact
Info
Li Kangchen Co-Founder, President & Vice Chairman
An Yubao Co-Founder, Chairman & Executive Director

Consun Pharmaceutical Group Board Members (2)

Name Representing Role Since Contact
Info
00 00000 Consun Pharmaceutical Group Co-Founder, Chairman & Executive Director 000 0000
00 00000000 Consun Pharmaceutical Group Co-Founder, President & Vice Chairman 000 0000